SEARCH

SEARCH BY CITATION

References

  • 1
    Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:20812095.
  • 2
    Moore KW, O’Garra A, De Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993; 11:165190.
  • 3
    Bogdan C, Nathan C: Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 1993; 685:713739.
  • 4
    Vieira P, De Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, DeVries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci 1991; 88:11721176.
  • 5
    Kim R, Emi M, Tanabe K: Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology 2006; 119:254264.
  • 6
    Lim S, Crawley E, Woo P, Barnes PJ: Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998; 352:113.
  • 7
    Shin HD, Winkler C, Stephens JL, Bream J, Young H, Goedert JJ, O’Brien T, Vlahov D, Buchbinder S, Giorgi J, Rinaldo C, Donfield S, Willoughby A, O’Brien SJ, Smith MW: Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL-10. Proc Natl Acad Sci 2000; 97:1446714472.
  • 8
    Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA: Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation. N Engl J Med 2003; 349:22012210.
  • 9
    Steinke JW, BarekZi E, Hagman J, Borish L: Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by Sp1. J Immunol 2004; 173:32153222.
  • 10
    Costa GC, Da Costa Rocha MO, Moreira PR, Menezes CA, Silva MR, Gollob KJ, Dutra WO: Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 2009; 199:451454.
  • 11
    Moore KW, De Waal Malefyt R, Coffman RL, O’Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683765.
  • 12
    Szony BJ, Bata-Csörgo Z, Bártfai G, Kemény L, Dobozy A, Kovács L: Interleukin-10 receptors are expressed by basement membrane anchored, alpha(6) integrin(+) cytotrophoblast cells in early human placenta. Mol Hum Reprod 1999; 5:10591065.
  • 13
    Huizinga TW, Van Der Linden MW, Deneys-Laporte V, Breedveld FC: Interleukin-10 as an explanation for pregnancy-induced flare in systemic lupus erythematosus and remission in rheumatoid arthritis. Rheumatology 1999; 28:496498.
  • 14
    Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:45624573.
  • 15
    Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliot JF, Mosmann T, Wegmann TG: IL-10 prevents naturally occurring fetal loss in the CBAxDBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is correction by in vivo injection of IFN-tau. J Immunol 1995; 154:42614268.
  • 16
    Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S: Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000; 164:57215728.
  • 17
    Plevyak M, Hanna N, Mayer S, Murphy S, Pinar H, Fast L, Ekerfelt C, Ernerudh J, Berg G, Matthiesen L, Sharma S: Deficiency of decidual IL-10 in first trimester missed abortion: a lack of correlation with the decidual immune cell profile. Am J Reprod Immunol 2002; 47:242250.
  • 18
    Simpson KL, Keelan JA, Mitchell MD: Labor-associated changes in interleukin-10 production and its regulation by immunomodulators in human choriodecidua. J Clin Endocrinol Metab 1998; 83:43324337.
  • 19
    Murphy SP, Fast LD, Hanna NN, Sharma S: Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 2005; 175:40844090.
  • 20
    Roberts CT, White CA, Wiemer NG, Ramsay A, Roberston SA: Altered placental development in interleukin-10 null mutant mice. Placenta 2003; 17:S94S99.
  • 21
    Roth I, Fisher SJ: IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 1999; 205:194204.
  • 22
    Borrego F: The First molecular basis of the “Missing Self” Hypothesis. J Immunol 2006; 177:57595760.
  • 23
    Poehlmann TG, Schaumann A, Busch S, Fitzgerald JS, Aguerre-Girr M, Le Bouteiller P, Schleussner E, Markert UR: Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1. Am J Reprod Immunol 2006; 56:275285.
  • 24
    Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P: IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11:803811.
  • 25
    Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ: Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184:539548.
  • 26
    Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y: Soluble HLA-G influences the release of cytokines from allogenic peripheral blood mononuclear cells in culture. Mol Hum Reprod 2001; 7:195200.
  • 27
    Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A: A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007; 37:19241937.
  • 28
    Blanco O, Tirado I, Muñoz-Fernández R, Abadía-Molina AC, García-Pacheco JM, Peña J, Olivares EG: Human decidual stromal cells express HLA-G: effects of cytokines and decidualization. Human Reprod 2008; 23:144152.
  • 29
    Choi BC, Polgar K, Xiao L, Hill JA: Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000; 15:S46S59.
  • 30
    Chaouat G, Tranchot Diallo J, Volumenie JL, Menu E, Gras G, Delage G, Mognetti B: Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. Am J Reprod Immunol 1997; 37:427434.
  • 31
    Lidstrom C, Matthiesen L, Berg G, Sharma S, Ernerudh J, Ekerfelt C: Cytokine secretion patterns of NK cells and macrophages in early human pregnancy decidua and blood: implications for suppressor macrophages in decidua. Am J Reprod Immunol 2003; 50:444452.
  • 32
    Simpson KL, Keelan JA, Mitchell MD: Labour-associated changes in the regulation of production of immunomodulators in human amnion by glucocorticoids, bacterial lipopolysaccharide and pro-inflammatory cytokines. J Reprod Fertil 1999; 116:321327.
  • 33
    Gustafsson C, Hummerdal P, Matthiesen L, Berg G, Ekerfelt C, Ernerudh J: Cytokine secretion in decidual mononuclear cells from term human pregnancy with or without labour: ELISPOT detection of IFN-gamma, IL-4, IL-10, TGF-beta and TNF-alpha. J Reprod Immunol 2006; 71:4156.
  • 34
    Murphy SP, Hanna NN, Fast LD, Shaw SK, Berg G, Padbury JF, Romero R, Sharma S: Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery. Am J Obstet Gynecol 2009; 200:19.
  • 35
    Thaxton JE, Romero R, Sharma S: TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009; 183:11441154.
  • 36
    Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, Nanan R: Systemic increase in the ratio between Foxp3 +  and IL-17-producing CD4 +  T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009; 183:70237030.
  • 37
    Kallikourdis M, Betz AG: Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus? PLoS ONE 2007; 2:382.
  • 38
    Zhao JX, Zeng YY, Liu Y: Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod Immunol 2007; 75:7181.
  • 39
    Zenclussen AC, Gerlof K, Zenclussen ML, Ritschel S, Zambon Bertoja A, Fest S, Hontsu S, Ueha S, Matsushima K, Leber J, Volk HD: Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur J Immunol 2006; 36:8294.
  • 40
    Saito S, Sasaki Y, Sakai M: CD4(+)CD25high regulatory T cells in human pregnancy. J Reprod Immunol 2005; 35:1120.
  • 41
    Jasper MJ, Tremellen KP, Robertson SA: Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 2006; 12:301308.
  • 42
    Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, Alexander T, Taran A, Malfertheiner SF, Costa SD, Zimmermann G, Nitschke C, Volk HD, Alexander H, Gunzer M, Zenclussen AC: Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol 2009; 182:54885497.
  • 43
    Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, Zhao L, An X, Du X, Chen X, Wang S, Xia G, Wang B: Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 2008; 214:456464.
  • 44
    Schumacher A, Wafula PO, Bertoja AZ, Sollwedel A, Thuere C, Wollenberg I, Yagita H, Volk HD, Zenclussen AC: Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy. Obstet Gynecol 2007; 110:11371145.
  • 45
    Blois SM, Barrientos G, Garcia MG, Orsal AS, Tometten M, Cordo-Russo RI, Klapp BF, Santoni A, Fernández N, Terness P, Arck PC: Interaction between dendritic cells and natural killer cells during pregnancy in mice. J Mol Med 2008; 86:837852.
  • 46
    Viganò P, Gaffuri B, Somigliana E, Infantino M, Vignali M, Di Blasio AM: Interleukin-10 is produced by human uterine natural killer cells but does not affect their production of interferon-gamma. Mol Hum Reprod 2001; 7:971977.
  • 47
    Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13:14501457.
  • 48
    Kalkunte S, Chichester CO, Gotsch F, Sentman CL, Romero R, Sharma S: Evolution of non-cytotoxic uterine natural killer cells. Am J Reprod Immunol 2008; 59:425432.
  • 49
    Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S: Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 2009; 182:40854092.
  • 50
    Tewari N, Kalkunte S, Murray DW, Sharma S: The water channel aquaporin 1 is a novel molecular target of polychlorinated biphenyls for in utero anomalies. J Biol Chem 2009; 284:1522415232.
  • 51
    Zeng L, O’Connor C, Zhang J, Kaplan AM, Cohen DA: IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines. Cytokine 2009; doi:10.1016/j.Cyto.2009.11.015.
  • 52
    Makris A, Xu B, Yu B, Thornton C, Hennessy A: Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 2006; 27:445451.
  • 53
    Daher S, Sass N, Oliveira LG, Mattar R: Cytokine genotyping in preeclampsia. Am J Reprod Immunol 2006; 55:130135.
  • 54
    Kamali-Sarvestani E, Kiany S, Gharesi-Fard B, Robati M: Association study of IL-10 and IFN-gamma gene polymorphisms in Iranian women with preeclampsia. J Reprod Immunol 2006; 72:118126.
  • 55
    Zammiti W, Mtiraoui N, Cochery-Nouvellon E, Mahjoub T, Almawi WY, Gris JC: Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion. Mol Hum Reprod 2006; 12:771776.
  • 56
    Kalkunte S, Lai Z, Norris WE, Pietras LA, Tewari N, Boij R, Neubeck S, Markert UR, Sharma S: Novel approaches for mechanistic understanding and predicting preeclampsia. J Reprod Immunol 2009; 83:134138.
  • 57
    Parikh SM, Karumanchi SA: Putting pressure on pre-eclampsia. Nat Med 2008; 14:855862.
  • 58
    Hennessy A, Pilmore HL, Simmons LA, Painter DM: A Deficiency of Placental IL-10 in Preeclampsia. J Immunol 1999; 163:34913495.
  • 59
    Wilczyński JR, Tchórzewski H, Głowacka E, Banasik M, Lewkowicz P, Szpakowski M, Zeman K, Wilczyński J: Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediators Inflamm 2002; 11:105111.
  • 60
    Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ, Erwich JJ: Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy 2009; 28:300311.
  • 61
    De Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW: Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun 2004; 5:313314.
  • 62
    Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer AE: Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16:855861.
  • 63
    Rezaei A, Dabbagh A: T-helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med Sci Monit 2002; 8:CR607CR610.
  • 64
    Hill JA, Polgar K, Anderson DJ: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995; 273:19331936.
  • 65
    Makhseed M, Raghupathy R, El-Shazly S, Azizieh F, Al-Harmi JA, Al-Azemi MM: Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol 2003; 49:308318.
  • 66
    Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E: Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196:122130.
  • 67
    Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, Sharma S: Evidence for interleukin-10-mediated inhibition of cyclo- oxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol 2006; 55:1927.